OTC Stock Change: Will ERBA DIAGNOSTICS (ERBA) Run Out of Steam Soon?

November 25, 2016 - By Marguerite Chambers

OTC Stock Change: Will ERBA DIAGNOSTICS (ERBA) Run Out of Steam Soon?

Interested investors have been looking for information on shares of ERBA DIAGNOSTICS (OTCMKTS:ERBA) after the stock moved $-0.009, hitting the $0.301 price point in a recent trade.

It’s the latest price, but let’s analyze how the stock has been doing recently. In the past year, ERBA DIAGNOSTICS’s stock was big mover. According to the short interest report published recently, (ERBA) had 34,200 shorted shares for 1.0 days to cover. The prior short interest was 39,300 for a $-12.98 change. The 52-Week High and Low are noted here. -85.53% (High), 173.64%, (Low). The stock had 33,800 average volume.

Enroll for Our Newsletter Today and know if shares price of ERBA DIAGNOSTICS (OTCMKTS:ERBA) is Ready to Breakout!

Penny stocks are often stated as risky investments that hardly pay off. Admittedly, there is fact to this, but with the right knowledge and tactics, it is possible to earn a significant amount of gain in penny stocks. Simply said, a penny stock is an equity that trades at a low price.

Irrespective of the name, penny stocks usually are priced over a penny, occupying a price range at or close to $1, though some are priced a fraction of a penny. Often referred to as micro-cap equities, the Securities & Exchange Commission classifies these types of securities as being $5 or less. Over-the-counter stocks are NOT listed on any of the formal exchanges.

So, penny stocks frequently fit in this segment, though many dodge this category. Over-the-counter (OTC) equities are stated to be risky as they aren’t contingent to the listing and reporting requirements of the reputed commodity exchanges.

Register in the Bar Below to Obtain Breaking Alerts on Shares That Are Set to Make a Move!

Penny shares can be listed on NASDAQ or other known stock exchanges, although many more cannot be found there. A major percentage of penny stocks are listed on the so-named ‘pink sheets’, i.e., daily news of OTC shares. They can even be seen on the ‘Over-the-Counter Bulletin Board.’ Commodities listed on the OTCBB fail to fulfill the listing guidelines of the NYSE or other known exchanges, although they are mandated to file financial statements with known regulators, such as the SEC. Penny shares are inexpensive, thus attractive to shareholders who lack the funds to buy comparatively expensive blue-chip stocks from large firms.

Penny stocks boast immense profit potential. Because these stocks trade cheap, even a slight jump in price turns to be profitable. Look out, however, because frequently shareholders may have trouble getting a decent amount of details about penny stocks. These kinds of shares tend to be latest in news, with almost no track record for investors research.

In addition, penny stocks show lack of market activity, with poor liquidity, making them difficult to sell. Poor liquidity results in penny stocks to be open to price influence.

A shady trader can simply buy large sums of shares, temporarily leading up the price, crafting artificial demand.

Disclaimer: Nothing mentioned in this publication is planned to constitute legal, securities, tax, or investment advice, nor a viewpoint regarding the relevance of any investment, nor any type of solicitation. The general information mentioned in this article should not be acted upon without getting specific tax, legal and investment advice from a certified professional.

More notable recent ERBA Diagnostics Inc (OTCMKTS:ERBA) news were published by: Globenewswire.com which released: “ERBA Diagnostics, Inc. Announces Non-Reliance on Previously Issued Financial …” on November 20, 2015, also Globenewswire.com with their article: “ERBA Diagnostics Inc. Annual General Meeting CEO’s Speech on the Company’s …” published on December 17, 2015, Globenewswire.com published: “ERBA Diagnostics, Inc. Appoints Ernesina Scala as Chief Financial Officer and …” on May 06, 2015. More interesting news about ERBA Diagnostics Inc (OTCMKTS:ERBA) were released by: Globenewswire.com and their article: “ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT …” published on May 20, 2016 as well as Marketwatch.com‘s news article titled: “ERBA Diagnostics Inc.” with publication date: November 11, 2016.

ERBA Diagnostics, Inc., through its subsidiaries, develops, makes and markets diagnostic test kits, or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology and diabetes testing. The company has a market cap of $22.04 million. The Company’s divisions include Domestic and European. It currently has negative earnings. The domestic region contains its subsidiaries located in the United States and in Latin American and corporate operations.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News